ICU and hospital mortality were lower for patients with cancer versus those without cancer.
Post-traumatic stress symptoms also linked to lower risk of readmission in hospitalized CA patients.
In subgroup analyses, reduced incidence of cancer seen in participants aged younger than 65 years.
Even among those exposed to high radiation doses, one-third not concerned about developing cancer.
Half of meds ID'd in expanded access programs treat cancer; others for metabolic, endocrine diseases
Even patients with mild chronic kidney disease were prevented from participating in clinical trials of drugs for bladder, breast, colorectal, lung, and prostate cancers.
Highest Healthy Eating Index scores associated with decreased overall and cancer-specific mortality.
From 2006 and 2016, smallest increase seen in high Sociodemographic Index countries.
Increased risk of subsequent diabetes independent of traditional diabetes risk factors.
Fulphila, biosimilar to Neulasta, helps reduce risk of infection during cancer treatment.
Benefit of palliative radiation for bone metastasis across age groups; older age should not preclude tx.
Lower rate of VTE recurrence, but higher clinically relevant non-major bleeding versus dalteparin.
Cryoablation also cuts the need for opioids at 24 hours post-treatment and at 3 months.
Magnitude of benefit of immune checkpoint inhibitors sex-dependent for patients with advanced cancers.
But majority of oncologists don't feel knowledgeable enough to make these recommendations
Findings based on survey of women with advanced cancer and dependent children.
PCC linked to reduction in hospital costs for hospitalized adults with serious illness.
Brief bedside session associated with improved positive mood, pain scores and decreased anxiety
More cancer survivors prescribed 5 or more unique medications, including those with abuse potential
After a median 20 years of follow-up, heart failure not associated with cancer incidence
Majority say they want to know about even minor consequences of cancer drug substitutions
Structure demonstrated to be part of the submucosa, supported by network of thick collagen bundles
Fatigability and poor endurance significantly higher in older adults with cancer history
Strongest associations found for lung and colorectal cancer
No evidence for circulating tumor DNA assays in early-stage cancer, residual disease detection
Inverse correlation for plasma 25-hydroxyvitamin D concentration with total cancer, liver cancer
Better reimbursement at hospital outpatient depts, even though drug-level costs lower in doctor's office
Fibrinogen, von Willebrand factor are potential markers of mortality in cancer survivors.
Reductions seen in fatigue symptom severity and fatigue-related quality of life disruption
Many young adult cancer survivors do not follow up properly, independent of disease type or insurance.
Renal and Urology News Articles
- Medication Adherence Low in Gout Patients Initiating Allopurinol
- Trials Supporting FDA Approval of Breakthrough Drugs Examined
- FDA Approves Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer
- Urine Cytology May Not Improve Hematuria Evaluation for Bladder Cancer
- Bladder Hydrodistention May Ease Nocturia in Interstitial Cystitis
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)